A sample of QSC HGH 36 IU Purple Top, manufactured by Qingdao Sigma Chemicals (QSC), was anonymously procured and submitted for independent laboratory analysis by Sampei, an individual consumer. The analysis was fully funded by the submitter, eliminating any potential conflicts of interest from the manufacturer. The purpose of the test was to verify the amount of recombinant human growth hormone (rHGH) in the vial, as well as its purity and presence of related proteins.
Laboratory analysis confirmed the vial contained 13.81 mg of rHGH, aligning with expected dosages for 36 IU vials. The purity level was measured at 96.532% and 96.537%, indicating high-quality recombinant HGH with minimal impurities. Additionally, dimer and related protein content was recorded at extremely low levels (0.063% and 0.036%), suggesting minimal degradation or protein aggregation.
Detailed Report
Product Overview
- Manufacturer: Qingdao Sigma Chemicals (QSC)
- Product Name: QSC HGH 36 IU Purple Top
- Batch Number: Purple Top
- Expiration Date: Not Provided
- Delivery Method: Injectable (Vial)
- Specification: 36 IU (approximately 12 mg/vial)
Sample Acquisition and Testing
- Task Number: #49982
- Testing Ordered: 23 SEP 2024
- Sample Received: 02 OCT 2024
- Analysis Conducted By: Janoshik
- Product Submitted By: Sampei (Individual)
- Analysis Paid For By: Sampei (Individual)
Testing Results
| Component/Test | Measured Result | Compliance/Remarks |
|---|---|---|
| Amount of rHGH in the vial | 13.81 mg; 13.81 mg | Meets expected dosage |
| Purity | 96.532%; 96.537% | High purity confirmed |
| Dimer & Related Proteins | 0.063%; 0.036% | Extremely low impurities |
Verification Details
- Verification URL: https://janoshik.com/tests/49982_M563G6VK7PZ1
- Originally published: https://thinksteroids.com/community/posts/3346282/
Evaluation of Independent Testing
The presence of recombinant HGH (rHGH) was confirmed in the sample, and the measured concentration was consistent with a 36 IU (12 mg) specification. The high purity level (96.5%) suggests an HGH product with minimal unwanted protein formations. Low dimer and related protein content further reinforces product quality and proper handling during production.
As the sample was independently procured by an individual rather than submitted by the manufacturer, these results hold greater credibility than manufacturer-funded testing, which may introduce biases through selective sample submissions.
Conclusion
The analysis of QSC HGH 36 IU Purple Top confirmed a high-purity, accurately dosed HGH product with minimal degradation or impurity levels. The findings suggest good quality control from the manufacturer and highlight the importance of third-party verification in ensuring product consistency.
Consumers should still remain vigilant by cross-referencing independent test results and considering additional third-party verifications to ensure continued batch-to-batch reliability.
Disclaimer
This report is published for educational and harm reduction purposes. Independent testing provides valuable insights; however, these findings pertain solely to the analyzed batch and may not represent the entire product line. Consumers are encouraged to critically assess this information alongside additional independent analyses.
